Fax: (813) 979-7287
Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma
A 6-year study
Article first published online: 16 DEC 2004
Copyright © 2004 American Cancer Society
Volume 105, Issue 1, pages 13–20, 25 February 2005
How to Cite
Cox, C., Centeno, B., Dickson, D., Clark, J., Nicosia, S., Dupont, E., Greenberg, H., Stowell, N., White, L., Patel, J., Furman, B., Cantor, A., Hakam, A., Ahmad, N., Diaz, N. and King, J. (2005), Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma. Cancer, 105: 13–20. doi: 10.1002/cncr.20738
- Issue published online: 11 FEB 2005
- Article first published online: 16 DEC 2004
- Manuscript Accepted: 8 SEP 2004
- Manuscript Revised: 26 JUL 2004
- Manuscript Received: 2 JUN 2004
- breast carcinoma surgery;
- imprint cytology;
The current report provides results from a large retrospective analysis of intraoperative imprint cytology performed on axillary sentinel lymph nodes (IICN) removed over the course of 2137 breast surgeries (4905 lymph nodes). It is hoped that these results may serve as benchmarks for those interested in using this technique.
The current study included 2078 patients with T1–2 invasive breast carcinoma who underwent sentinel lymph node biopsy (SLNB) and IICN. Lymph nodes were bivalved, imprinted, stained with Diff-Quik (Baxter Diagnostics, McGaw Park, IL), and reviewed by a cytopathologist. A positive intraoperative diagnosis led to immediate complete axillary lymph node dissection (CALND). On final pathology, lymph nodes found to be negative on hematoxylin and eosin staining were submitted for cytokeratin staining.
Of the 2137 cases for which SLNB was performed, 673 were found to have positive lymph node status on final pathology. Of these 673 cases, 359 were identified by IICN, resulting in a sensitivity rate of 53.3%. The specificity and overall accuracy rates for this technique were 99.5% and 85.0%, respectively. In IDC cases, IICN had a sensitivity rate of 55.5%, compared with 38.7% in ILC cases. Based on these results, the reoperative CALND rate was calculated to be approximately 14.7%, with 54.5% of these reoperative procedures being performed for cases in which lymph nodes positive only for micrometastases were found. Macrometastasis-positive lymph nodes that went undetected by IICN were present in only 154 of the 2137 cases examined (7.2%).
IICN accurately predicts final lymph node status in 85.0% of patients. Although the accuracy of this technique varies with tumor size and type, IICN remains a time-efficient and cost-effective adjunct to SLNB. Cancer (Cancer Cytopathol) 2005. © 2004 American Cancer Society.